Nu Skin Enterprises with ticker code (NUS) have now 5 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price and low target price is between 61 and 47 and has a mean target at 53.6. Given that the stocks previous close was at 52.68 this is indicating there is a potential upside of 1.7%. The 50 day moving average now sits at 47.5 while the 200 day moving average is 50.74. The market capitalisation for the company is $2,639m. Visit the company website at: https://www.nuskin.com
Nu Skin Enterprises develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises was founded in 1984 and is headquartered in Provo, Utah.
